Robotic Surgical Outcomes in Endometrial Cancer: Does Class III Obesity Matter?
Cancers · 22.02.2026 · 18 (4) · 706
DOI: 10.3390/cancers18040706 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancers, online erschienen am 22.02.2026. Verfasst von Vito Andrea Capozzi und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, University of Parma, 43125 Parma, Italy. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background/Objective: Women with Class III obesity (BMI ≥ 40 kg/m2) have a lifetime risk of endometrial cancer (EC) as high as 10–15%. However, evidence focused specifically on Class III obese patients remains limited. This study evaluated the surgical feasibility and safety of robotic surgery in Class III obese women with EC.
Methods
A single-center retrospective study was conducted at the ESGO-accredited University Hospital of Parma (Italy) from October 2021 to February 2025. All women had apparent early-stage EC and underwent robotic hysterectomy with bilateral salpingo-oophorectomy and sentinel lymph node (SLN) mapping with Indocyanine Green. Patients were categorized into three BMI groups: Group A (BMI ≥ 40 kg/m2), Group B (BMI 30–39 kg/m2), and Group C (BMI < 30 kg/m2). Perioperative variables—including operative time, estimated blood loss, conversion to laparotomy, intra- and postoperative complications, hospital and Intensive Care Unit (ICU) stay, and SLN mapping failure—were compared across groups.
Results
A total of 109 women were included: 26 (23.9%) in Group A, 45 (41.3%) in Group B, and 38 (34.9%) in Group C. Class III obesity was not associated with higher intraoperative (p = 0.390) or postoperative (p = 0.805) complication rates. Conversion to laparotomy (p = 0.720), estimated blood loss (p = 0.123), ICU stay (p = 0.156), and hospital stay (p = 0.491) were superimposable across groups. Operative time was significantly longer in Group A (p = 0.003) compared to the other groups. Successful bilateral SLN mapping differed significantly across groups (p = 0.026), being lower in Group A (73.1%) compared to Group B (95.6%) and Group C (81.6%).
Conclusions
Robotic surgery is safe and feasible in Class III obese EC patients, with perioperative morbidity comparable to that of lower BMI groups. Nevertheless, longer operative times and a lower rate of successful bilateral SLN mapping highlight the need for tailored strategies and further research to optimize nodal staging in severely obese women.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, University of Parma, 43125 Parma, Italy.
- Department of Medical and Surgical Sciences (DIMEC), University of Bologna, 40126 Bologna, Italy.
- Department of Maternal and Child Health, "Santa Maria della Misericordia" University Hospital, Azienda Sanitaria Universitaria Friuli Centrale (ASUFC), 33100 Udine, Italy.
ORCID-Profile: Vito Andrea Capozzi, Elisa Scarpelli, Stefano Restaino, Giuseppe Vizzielli, Roberto Berretta
Zitieren
APA
Capozzi, V. A., Gallinelli, A., Scarpelli, E., Restaino, S., Vizzielli, G., & Berretta, R. (2026). Robotic Surgical Outcomes in Endometrial Cancer: Does Class III Obesity Matter?. Cancers, 18(4), 706. https://doi.org/10.3390/cancers18040706
Vancouver
Capozzi VA, Gallinelli A, Scarpelli E, Restaino S, Vizzielli G, Berretta R. Robotic Surgical Outcomes in Endometrial Cancer: Does Class III Obesity Matter?. Cancers. 2026;18(4):706. doi:10.3390/cancers18040706
BibTeX
@article{Capozzi2026,
author = {Capozzi, Vito Andrea and Gallinelli, Asya and Scarpelli, Elisa and Restaino, Stefano and Vizzielli, Giuseppe and Berretta, Roberto},
title = {Robotic Surgical Outcomes in Endometrial Cancer: Does Class III Obesity Matter?},
journal = {Cancers},
year = {2026},
volume = {18},
number = {4},
pages = {706},
doi = {10.3390/cancers18040706}
}
EUVIMED